{
 "PrintNo":"S1776","Session":2021,"Chamber":"SENATE","BillType":"Senate","Published":"2021-01-15T13:49:20.900054Z",
 "Status":"IN_SENATE_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_SENATE_COMM","Date":"2022-01-05","Committee":"Health"}],
 "Actions":[
  {"Text":"REFERRED TO HEALTH","Date":"2021-01-15","Chamber":"SENATE"},
  {"Text":"REFERRED TO HEALTH","Date":"2022-01-05","Chamber":"SENATE"}
 ],
 "Sponsors":[{"ID":1232,"Name":"James Skoufis","Short":"SKOUFIS"}],
 "Title":"Adds tianeptine sodium to the list of Schedule II of controlled substances",
 "Summary":"Adds tianeptine sodium to list of Schedule II of controlled substances.","LawSection":"Public Health Law",
 "LawCode":"Amd ยง3306, Pub Health L",
 "ActClause":"AN ACT to amend the public health law, in relation to adding tianeptine sodium to schedule II of controlled substances",
 "SameAsPrintNo":"A344-2021","PreviousVersions":["S8023-2019"]
}